Percutaneous coronary intervention and Gingival bleeding

Summary:

Gingival bleeding is found among people with Percutaneous coronary intervention, especially for people who are male, 60+ old.

The study analyzes which people have Gingival bleeding with Percutaneous coronary intervention. It is created by eHealthMe based on reports of 12 people who have Percutaneous coronary intervention from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Percutaneous coronary intervention?

Percutaneous coronary intervention is found to be associated with 40 drugs and 131 conditions by eHealthMe. Check the latest studies of Percutaneous coronary intervention.

What is Gingival bleeding?

Gingival bleeding (bleeding gums) is found to be associated with 1,030 drugs and 1,082 conditions by eHealthMe. Check the latest studies of Gingival bleeding.



On Jul, 12, 2026

12 people who have Percutaneous Coronary Intervention and Gingival Bleeding are studied.

Would you have Gingival bleeding when you have Percutaneous coronary intervention?

Gender of people who have Percutaneous Coronary Intervention and experienced Gingival Bleeding *:

  • female: 11.11 %
  • male: 88.89 %

Age of people who have Percutaneous Coronary Intervention and experienced Gingival Bleeding *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25.0 %
  • 50-59: 12.5 %
  • 60+: 62.5 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 2 people, 16.67%
  2. Prostatomegaly (enlargement of the prostate): 1 person, 8.33%
  3. Heart Attack: 1 person, 8.33%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 8.33%

Common drugs taken by these people *:

  1. Clopidogrel: 5 people, 41.67%
  2. Angiomax: 5 people, 41.67%
  3. Aspirin: 3 people, 25.00%
  4. Effient: 2 people, 16.67%
  5. Warfarin Sodium: 1 person, 8.33%
  6. Tamsulosin: 1 person, 8.33%
  7. Rivaroxaban: 1 person, 8.33%
  8. Reopro: 1 person, 8.33%
  9. Ramipril: 1 person, 8.33%
  10. Plavix: 1 person, 8.33%

Common symptoms for these people *:

  1. Urogenital Haemorrhage (bleeding from urogenital): 2 people, 16.67%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
  3. International Normalised Ratio Increased: 1 person, 8.33%
  4. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 1 person, 8.33%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 8.33%
  6. Eye Movement Disorder: 1 person, 8.33%
  7. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 8.33%
  8. Haematoma (collection of blood outside the blood vessels): 1 person, 8.33%
  9. Haematuria (presence of blood in urine): 1 person, 8.33%
  10. Haemoglobin Decreased: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gingival bleeding?

- Check whether Gingival bleeding is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Gingival bleeding:

All the conditions that are associated with Gingival bleeding:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Gingival bleeding and Percutaneous coronary intervention, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: